Angioplasty
Most Popular Angioplasty Web Site
   
Medtronic's CoreValve/Evolut™ Transcatheter Aortic Valve
Three-Year Results of Medtronic's Evolut TAVR Compared to Surgery in Low Risk Patients Presented at ACC
The 3-year comparative data for Medtronic's CoreValve/Evolut TAVR vs. SAVR for low risk patients that were presented at today's late-breaking clinical trials session were much needed and the results showed that this device compared favorably with surgery and, in some respects, was superior.
Abbott's Amplatzer Amulet Left Atrial Appendage Occluder and Navitor Transcatheter Aortic Valve
New Data Show Superiority of Abbott's TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation
Late-breaking data demonstrated TriClip was superior to medical therapy with significant improvements in quality of life and tricuspid regurgitation (TR). Findings show TriClip, an investigational device in the U.S. to treat a leaky tricuspid valve, demonstrated safety and met the primary endpoint.
Medtronic's CoreValve/Evolut™ Transcatheter Aortic Valve
Medtronic CoreValve/Evolut™ Durability Bests SAVR at 5-Years
Data were presented in a late-breaking clinical trial session at CRT 2023 by Dr. Steven Yakubov: "These results add yet another proof point demonstrating the durability benefits of TAVR compared to surgery when it comes to bioprosthetic valve dysfunction – a complication that can impact the durability and performance of a critical valve replacement."
altname
Updated SCAI Guidance Includes Coronary IVL as a Treatment Option in All U.S. Catheterization Labs Regardless of Surgical Backup Status
Shockwave Medical, Inc. announced that coronary IVL was included in a treatment guidance document published by the Society of Cardiovascular Angiography and Intervention (SCAI) as a potential therapeutic option in all U.S. catheterization labs. - including facilities without on-site surgical backup.
altname
SPYRAL HTN-ON MED Study Demonstrates Meaningful Clinical Benefits Consistent with Other SPYRAL HTN Renal Denervation Trials
At the American Heart Association (AHA) Scientific Sessions 2022, Medtronic announced the six-month results from the full cohort of the SPYRAL HTN-ON MED clinical trial. With this news, the final module of the Symplicity Spyral™ Premarket Approval (PMA) package has been submitted to the U.S. Food and Drug Administration (FDA) for review and approval.
Dr. Alexandra Lansky
Shockwave Medical Initiates All-Female Coronary IVL Study
EMPOWER CAD is the 1st prospective, female-only study of coronary interventions. The study seeks to confirm benefits of Shockwave’s coronary IVL in females who historically have suffered less favorable clinical outcomes than male patients with traditional therapies. The study is headed by two female co-principal investigators, Drs. Alexandra Lansky and Margaret McEntegart, and will have a prevalence of female site investigators in the U.S. and Europe.
altname
Medtronic Launches Newest Drug-Eluting Stent: The Onyx Frontier™
The major improvement is that it employs a more deliverable system: an innovative dual-layer balloon, a lower profile for crossing, and increased catheter flexibility. These refinements point to a 16% improvement in deliverability vs. the previous generation while maintaining superior radial strength.
Projected Number of Patients in U.S. with Ischemic Heart Disease 2025-2060
New US Population Study Projects Steep Rise in Cardiovascular Diseases by 2060
Study projects substantial changes in the prevalence of CV risk factors and disease in the U.S. population by 2060, with an increasing prevalence among Black and Hispanic populations who have historically experienced poor access to quality health care. Targeted efforts toward improved screening and equitable access to quality health care in populations with the greatest growth in CV risk factors or disease would be expected to have a substantial impact to reduce future CV risk for the population overall.
FFRangio display
Non-Invasive FFR Gets Boost from Medtronic
FFRangio was developed by CathWorks, an Israeli company, and was approved by the US FDA in 2018. The pivotal study that led to FDA approval, FAST-FFR, showed that angiography-derived FFR was highly accurate when compared with pressure-wire FFR. This week Medtronic announced that it was investing $75 million in the company, co-promoting its use, and has an option to acquire CathWorks for $585 million, once certain milestones are met.
Medtronic's Onyx Drug-Eluting Stent (DES)
Two-Year Results from Onyx ONE Trial: No Difference Between Onyx DES and BioFreedom DCS
The results, consistent with the outcomes seen at one year, showed that at two years there were no differences between HBR patients on one month of DAPT who received the Onyx permanent polymer drug-eluting stent (DES), made by Medtronic, and those who received the BioFreedom polymer-free drug-coated stent (DCS), made by Biosensors.
MitraClip, manufactured by Abbott
Late-Breaking Data Reinforce Broad Range of Patients Benefit from Abbott's Mitral and Tricuspid Heart Valve Devices
1-year results for the MitraClip EXPAND study and 30-day data on the TriClip and TriClip G4 TEER systems were presented at today's session of TVT2022
Panel discusses renal denervation
at EuroPCR 2022
Renal Denervation for Controlling Hypertension Featured at EuroPCR
At this year's EuroPCR meeting in Paris, the largest European conference in the field of interventional cardiology, the topic of renal denervation (RDN) resurfaced with significant positive results from several trials across devices.
Interventional Cardiologist Dr. Sanjay Patel
"The Whole Story is About Increasing Patient Happiness."
Interview with Dr. Ferdinand Kiemeneij
In this two-part 20th anniversary interview, the "father of transradial intervention, " talks about the history and future of TRI.

Angioplasty News

RSS Angioplasty News Feed Get our RSS News Feed
Shockwave Medical Announces U.S. Launch of New Peripheral IVL Catheter (Mar 14)
3-Year Results of Medtronic's Evolut TAVR Compared to Surgery in Low Risk Patients Presented at ACC (Mar 5)
New Data Show Superiority of Abbott's TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation (Mar 4)
CathWorks Announces Key Events for ACC 2023 (Mar 2)
Late-Breaking Data Reinforce Benefits of Abbott's Minimally Invasive Heart Devices (Feb 28)
Medtronic CoreValve/Evolut™ Demonstrates Best Durability (Feb 27)
Medtronic Continues to Make Significant Advances as an Inclusion, Diversity & Equity Leader (Feb 1)
Lithotripsy OK for PCI w/o Surgical Backup (Jan 31)
Medtronic Announces first Enrollment in Head-to-Head Global Randomized Trial Evaluating Durability of Endovascular Aneurysm Repair (Jan 11)
Medtronic Completes Enrollment in Pivotal Trial Evaluating First-Of-Its-Kind Pulsed Field Ablation Catheter for Patients with Atrial Fibrillation (Dec 5)
Medtronic’s Next-Gen Evolut™ FX TAVR System Shows Significant Improvement in Commissure Alignment in Real World Setting (Nov 29)
Late-Breaking Post-Market Study Data Reinforce Clinical Procedural Success and Safety of the ACURATE neo2™ Aortic Valve System (Nov 27)
SPYRAL HTN-ON MED Study Demonstrates Meaningful Clinical Benefits Consistent with Other SPYRAL HTN Renal Denervation Trials (Nov 7)
Medtronic is the First and Only Company to Receive FDA Indication for Bifurcation Percutaneous Coronary Intervention with a Drug-Eluting Stent (Sep 21)
FDA OKs LINQ II™ Insertable Cardiac Monitor for Use in Pediatric Patients Ages 2 and Older (Sep 20)
Shockwave Medical Initiates All-Female Coronary IVL Study (Sep 19)
3 YR Data from Pioneering RDN Study Show Sustained Reduction in Blood Pressure (Sep 18)
Medtronic Announces Full Market Launch in U.S. of Evolut™ Fx Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis (Sep 16)
Medtronic Launches Newest Drug-Eluting Stent: The Onyx Frontier™ (Aug 24)
JACC: Steep Rise in CV Risk Factors & Disease by 2060 (Aug 1)
Non-Invasive FFR Gets Boost from Medtronic (Jul 17)
2-Year Outcomes from Onyx ONE Published in JACC: Interventions (Jun 9)
1-Year Results for MitraClip EXPAND and 30-Day Data on TriCLip Presented at TVT2022 (Jun 8)
Renal Denervation for Controlling Hypertension Featured at EuroPCR (May 29)
Medtronic Low-Profile Drug-Coated Balloon Platform Receives U.S. FDA Approval to Treat Peripheral Arterial Disease (May 27)
Shockwave's Coronary and Peripheral Intravascular Lithotripsy Systems Gain Approval in China (May 23)
Significantly Improved Results for Medtronic's Evolut TAVR seen in the Optimize PRO Study (May 21)
Intravascular Lithotripsy May Emerge as a First-Line Therapy for Calcified Lesions in Women (May 19)
2nd Gen ACURATE neo2 TAVR Reduces PVL by 2/3 (May 18)
Medtronic Receives FDA Approval for Latest Generation Drug-Eluting Coronary Stent System (May 13)
Medtronic Announces First Enrollment in Pivotal Trial of Patients with Moderate, Symptomatic Aortic Stenosis (May 2)
IN.PACT™ AV Drug-Coated Balloon First and Only to Show Sustained and Superior Performance Compared to PTA Through 36 Months (Apr 27)
Medtronic Names New Chief Scientific, Medical, & Regulatory Officer (Apr 25)
BioFreedom DCS Gains Approval in Japan and U.S. (Apr 21)
Medtronic TAVR Platform First and Only To Demonstrate Durability Benefit Over SAVR At 5 Years (Apr 4)
Japan OK for Shockwave Coronary Intravascular Lithotripsy (Apr 2)
FDA Approval and First Implant of Orsiro Mission Drug-Eluting Stent System in the U.S. (Sep 30)
Medtronic Portfolio of Radial Catheters Gains CE Mark (Sep 28)
Emergency: Climate Crisis! Editorial from The Lancet (Sep 5)
FDA Oks Next Gen TAVR SYstem from Medtronic (Aug 24)
Medtronic's Prevail DCB Gets CE Mark for Coronary Use (July 27)
1st Patient Enrolled in Philips DEFINE GPS Study (July 22)
Herb Aronow New President of Society for Vascular Medicine (June 18)
CMS Grants Shockwave IVL TPT Outpatient Reimbursement (Jun 11)
2-Year Data Confirms Evolut TAVR Non-inferior to Open Surgery in Low Risk Patients (May 31)
Medtronic's Evolut Pro+ TAVI System Gets CE Mark (May 3)
Shockwave IVL May Get CMS Reimbursement (Apr 27)
FDA OK to Philips Azurion SmartCT Imaging Software (Apr 6)
Harmony Transcatheter Pulmonary Valve Gets FDA OK (Mar 26)
Visit current news, and news archives

Burt Cohen, Editor of Angioplasty.Org
"Voice in the Ear": Editor Burt Cohen's stent and device blog.

Recent Posts:

The Activated Patient
"The Activated Patient": Patient info and empowerment blog
Patients Are Talking About...
  • I had radial angiography 2 days ago...it was a fascinating experience and was able to watch part of the procedure. I feel fantastic, have no "heart ache" or any problems with my arm.
  • I can't afford my post-stenting meds, where can I find help paying for Plavix or Effient?
  • I'm 64. After 4 stents and 2 heart attacks since Dec. 2008, I'm as physically active or more so than ever. I plan to hit 4,000 miles on my bike this year. I've hiked/climbed at 13,000 feet.
Patients Are Reading About...
5 Crucial Questions To Ask Your Doctor About New Heart Disease Treatments
Make sure you are benefiting from the most up-to-date research, and have access to the treatments that best fit your needs and preferences.
   Doctor and Patient
Radial Hospital Locator
A list of physicians and hospitals offering the transradial (wrist) approach to angiograms, angioplasty and stent procedures.
  Transradial Hospital
Read patient stories and Learn about medications after stenting, symptoms and complications, care giving, taking charge of your health, communicating with your cardiologist and much more in our Patient Center.
Angioplasty Inventor, Dr. Andreas Gruentzig
see video clip:
" The 1st Angioplasty"
ANGIOPLASTY AT 40: 2017 marked the 40th anniversary of coronary angioplasty. In 1977 in Zurich, Switzerland, a young physician named Andreas Gruentzig inserted a catheter into a patient's coronary artery and inflated a tiny balloon, successfully opening a blockage and restoring blood flow to a human heart.
Today over two million coronary angioplasties are performed worldwide each year and angioplasty has become the gold standard for emergency heart attack treament.
(View videos, interviews, and photos in our Angioplasty History Center, or order our DVD, "PTCA: A History.") Angioplasty History DVD
What People Are Saying About Angioplasty.Org:
"Everyone, please consider donating to this site, it is a wealth of information and comfort. Where else can you get such great information AND expedited? My dr's don't return phone calls as quickly as I've gotten responses here!" -- Denise, Connecticut, USA
"Angioplasty.Org is awesome; I always refer patients to it. It makes a difference big time. They go and they look and see all the people interviewed and these well-known cardiologists around the world talking about it, and it takes that anxiety away." -- Sanjay Patel, MD, Houston, Texas, USA
"Thanks to Angioplasty.Org for all the info which helped a lot in my decision making and post procedure recovery." -- Muralidharan, Chennai, India
"Burt Cohen (Senior Editor of Angioplasty.Org) has been documentarian of this field of medicine for 30 years" -- Dr. Stephen Oesterle, SVP Medicine and Technology, Medtronic Corp.
"I just want you to know that you probably saved [my husband's] life by telling your story, and I want to thank you for it." -- Marie, Canada
Thank You to Our Industry Grantmakers:
Medtronic, Inc.
TCROSS NEWS
Volcano Corporation
Toshiba America
Medical Systems
Cardium Therapeutics
Lenox Hill Heart and Vascular Institute of NY
Freddie Award for International Health and Medical Media
Britannica Selection
Selected as an "Internet iGuide" by Encyclopedia Brittanica
    Health On the Net


send comments & suggestions to "info at angioplasty dot org"
Read our Privacy statement.

Angioplasty.Org is an editorially independent informational health site
which has received unrestricted educational grants from
Medtronic plc, TCROSS NEWS, Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY

For more information, see About Us
All content, including text, photos and video
© Copyright Venture Digital LLC 1996-2023